After-Hours Stock Movers 05/09: AMC, RingCentral Gain on Earning; Upstart, GoodRx Plunge Lower (more...)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/13/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Super Micro Computer establishes $1.25 billion stock sale agreement
- Wall Street ends higher as SpaceX's market debut dominates
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- SpaceX Shares Indicated To Open At $155
Microchip Technology (MCHP) PT Lowered to $100 at Jefferies
May 10, 2022 8:42 AM EDTJefferies analyst Mark Lipacis lowered the price target on Microchip Technology (NASDAQ: MCHP) to $100.00 (from $109.00) while maintaining a Buy rating.
The analyst commented, "MarQ revs/EPS were 1%/2% above consensus. JunQ rev and outlook are both 5% above. JunQ rev outlook assumes 6% QQ growth and... More
RingCentral (RNG) PT Lowered to $100 at Jefferies
May 10, 2022 8:40 AM EDTJefferies analyst Samad Samana lowered the price target on RingCentral (NYSE: RNG) to $100.00 (from $120.00) while maintaining a Buy rating following earnings.
The analyst commented, "RNG beat consensus for total rev, ARR and margins. While the headline #'s were solid, sub rev and... More
Microchip Technology (MCHP) PT Lowered to $90 at Needham & Company
May 10, 2022 7:58 AM EDTNeedham & Company analyst Rajvindra Gill lowered the price target on Microchip Technology (NASDAQ: MCHP) to $90.00 (from $105.00) while maintaining a Buy rating following earnings.
The analyst commented, "Heading into MCHP's 4QF22 report, the SOX hit new lows for the year as sentiment on... More
GoodRx Holdings Inc. (GDRX) PT Lowered to $12 at Goldman Sachs
May 10, 2022 7:00 AM EDTGoldman Sachs analyst Eric Sheridan lowered the price target on GoodRx Holdings Inc. (NASDAQ: GDRX) to $12.00 (from $30.00) while maintaining a Buy rating.
The analyst commented, "In its Q1 22 earnings report, GoodRx presented a solid quarterly report but framed the forward business trajectory as impacted by a "grocer" partner that had... More
Citi Downgrades Upstart Holdings Inc (UPST) to Neutral
May 10, 2022 6:17 AM EDTCiti analyst Peter Christiansen downgraded Upstart Holdings Inc (NASDAQ: UPST) from Buy to Neutral with a price target of $50.00.
The analyst comments "Our thesis going into 1Q22 results recognized that consumer credit has been normalizing. Yet our expectation was that loan performance on recent... More
